Characteristics

Adenocarcinoma (n = 27)

Squamous cell carcinoma (n = 42)

Age (years)

63.18

65.85

Gender

20 male (74.1%)

7 female (25.9%)

41 male (97.6%)

1 female (2.4%)

Operation type

Pneumectomy: 3 (11.1%)

Lobectomy: 22 (81.5%)

Bilobectomy: 2 (7.4%)

Pneumectomy: 10 (23.8%)

Lobectomy: 27 (64.3%)

Bilobectomy: 5 (11.9%)

Lymphnodes resected (n)

17.8 ± 6.8

20.9 ± 8.6

Pathologic Stage (UICC 2010)

IA: 3 (11.1%)

IB: 13 (48.1%)

IIA: 1 (3.7%)

IIB: 4 (14.8%)

IIIA: 6 (22.2%)

IA: 3 (7.1%)

IB: 12 (28.6%)

IIA: 9 (21.4%)

IIB: 8 (19.0%)

IIIA: 9 (21.4%)

IIIB: 1 (2.4%)

T parameter

T1a: 17 (18.5%)

T1b: 6 (22.2%)

T2a: 10 (37.0%)

T2b: 4 (14.8%)

T3: 2 (7.4%)

T1a: 3 (7.1%)

T1b: 7 (16.7%)

T2a: 13 (31.0%)

T2b: 9 (21.4%)

T3: 7 (16.7%)

T4: 3 (7.1%)

N parameter

N0: 17 (63%)

N1: 16 (14.8%)

N2: 6 (22.2%)

N0: 27 (64.3%)

N1: 9 (21.4%)

N2: 5 (11.9%)

N3: 1 (2.4%)

Grading

1˚ Grade: 1 (3.7%)

2˚ Grade: 17 (63.0%)

3˚ Grade: 9 (33.3%)

2˚ Grade: 28 (66.7%)

3˚ Grade: 14 (33.3%)

Mean follow up time (month)

35 ± 27.9

51.5 ± 35.9